Medical News

RSS
Quad introduces MagCloudz Streptavidin Cell Separation Kit to redefine translational medical research

Quad introduces MagCloudz Streptavidin Cell Separation Kit to redefine translational medical research

Experts to gather at DOHaD congress to address challenges that impact health of children, adolescents

Experts to gather at DOHaD congress to address challenges that impact health of children, adolescents

Unwanted formation of blood vessels in the brain may cause intractable difficulties for Parkinson's disease patients

Unwanted formation of blood vessels in the brain may cause intractable difficulties for Parkinson's disease patients

Research shows why osteoarthritis and hip changes are more frequent in athletes

Research shows why osteoarthritis and hip changes are more frequent in athletes

JEDI T-cells provide unique technology to study, visualize immune responses and immunotherapies

JEDI T-cells provide unique technology to study, visualize immune responses and immunotherapies

Hospital evidence-based practice centers can effectively inform decision-making in medical settings

Hospital evidence-based practice centers can effectively inform decision-making in medical settings

Nucala (mepolizumab) approved for treatment of asthma patients

Nucala (mepolizumab) approved for treatment of asthma patients

EndoGastric Solutions announces assignment of relative value units for new CPT code covering TIF procedure

EndoGastric Solutions announces assignment of relative value units for new CPT code covering TIF procedure

Linkam stages in use in the Wolfson Bioimaging Facility at the University of Bristol as part of the endocytic sorting research of Dr Paul Verkade

Linkam stages in use in the Wolfson Bioimaging Facility at the University of Bristol as part of the endocytic sorting research of Dr Paul Verkade

Perisylvian polymicrogyria gene found

Perisylvian polymicrogyria gene found

Urinary biomarkers for bladder cancer diagnosis fall short of mark

Urinary biomarkers for bladder cancer diagnosis fall short of mark

Sanford Research scientists develop animal model to study neurodegenerative disease

Sanford Research scientists develop animal model to study neurodegenerative disease

Children's Cancer Institute licenses Labmatrix to support 'Zero Childhood Cancer' program

Children's Cancer Institute licenses Labmatrix to support 'Zero Childhood Cancer' program

ReDy receives CE clearance for third-generation Renal Denervation System

ReDy receives CE clearance for third-generation Renal Denervation System

Sexual dysfunction prevalent among recent combat veterans

Sexual dysfunction prevalent among recent combat veterans

SMU and University of Maryland researchers awarded NIH grant to combat pediatric asthma

SMU and University of Maryland researchers awarded NIH grant to combat pediatric asthma

Researchers track re-emergence of scarlet fever-causing bacteria

Researchers track re-emergence of scarlet fever-causing bacteria

Study evaluates effectiveness of antiretroviral treatment in HIV-infected children

Study evaluates effectiveness of antiretroviral treatment in HIV-infected children

Johnson & Johnson signs definitive agreement to purchase Novira Therapeutics

Johnson & Johnson signs definitive agreement to purchase Novira Therapeutics

Addressing quality of life needs in prostate cancer: an interview with Professor Louis Denis

Addressing quality of life needs in prostate cancer: an interview with Professor Louis Denis

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.